New York, NY – WindRose Health Investors, LLC (“WindRose”), the healthcare-focused private equity fund, has closed its fifth fund, WindRose Health Investors V, L.P. (“Fund V”) with $705 million in limited partner and general partner commitments. The fund was over-subscribed and closed at its fundraising cap.
WindRose Managing Partner, Oliver T. Moses, said, “It is gratifying to see our team’s strategy and track record so well received in the market. We are grateful for the trust placed in us by a distinguished group of investors and will work diligently to execute our plan.” Fund V will continue WindRose’s focus on investing in businesses that operate in the services sectors of healthcare. Although the healthcare industry is expanding, not all areas of healthcare are equally positioned for rapid growth. WindRose targets sectors that are poised to benefit from the strongest industry tailwinds and companies that differentiate themselves by delivering innovative and cost-effective solutions.
The senior investment team at WindRose has been investing together for well over a decade and has over 80 years of combined experience working with healthcare businesses. WindRose Founding Partner, Curtis S. Lane, said, “WindRose’s deep domain knowledge and extensive network of healthcare industry relationships equips us to identify attractive investment targets and to bring new growth opportunities to each of the companies with which we partner.”
WindRose is based in New York City and makes investments in companies throughout the United States. The firm manages over $1.4 billion of capital. For more information, please email us at firstname.lastname@example.org.
Weil Gotshal & Manges LLP served as legal counsel in the fund formation of Fund V.